—Most patients with paroxysmal nocturnal hemoglobinuria who have been treated with at least 1 year of C5 inhibitor therapy still have hemoglobin levels below 12.0 g/dL. Continued fatigue and other ...

Post hoc analyses of the phase 3 PEGASUS trial found that clinical and hematological improvements were associated with better patient-reported fatigue and physical function outcomes in paroxysmal ...

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, progressive, multi-system, life-threatening disease, and diagnosing it early in the clinical course is essential for optimizing management ...

CHEST discomfort associated with paroxysmal nocturnal dyspnea is frequently quite distressing, and some patients describe this discomfort as pain. 1 During the past several years, we have noted in the ...

AJMC ®: Paroxysmal nocturnal hemoglobinuria (PNH) is 1 of several complement-driven diseases. Can you describe its clinical presentation? DE CASTRO: PNH presents heterogeneously. One of the 3 ...

The first-in-class complement factor D inhibitor danicopan (Voydeya) has been approved by the European Commission as an add-on agent for certain patients with the rare disease paroxysmal nocturnal ...

The National Institute for Health and Care Excellence (NICE) has recommended crovalimab (Piasky) for the treatment of paroxysmal nocturnal haemoglobinuria (PNH) in adults and some paediatric patients ...

Paroxysmal nocturnal hemoglobinuria (PNH) means that red blood cells break down before they should. This can lead to chronic, highly individual effects that often include bloody urine, anemia, and ...

Paroxysmal nocturnal hemoglobinuria leaves red blood cells more vulnerable to destruction. A common side effect is blood clots, known as thrombosis. This is largely preventable with medication to ...

Case 1. A.C. (P.A.S.H. 21–59–29), a 62-year-old man, was admitted to the hospital on September 19, 1966, because of paroxysmal nocturnal dyspnea. In 1957 he was noted to have an aortic diastolic ...

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disease in which changes in stem cells within the bone marrow prompt red blood cells to break apart. This deprives the body of the normal flow ...